| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042665321 |
| P356 | DOI | 10.1007/S10549-015-3528-7 |
| P932 | PMC publication ID | 6043784 |
| P698 | PubMed publication ID | 26250393 |
| P5875 | ResearchGate publication ID | 280868525 |
| P50 | author | Justin Xavier Moore | Q51125987 |
| Tomi Akinyemiju | Q63542026 | ||
| P2093 | author name string | Sean F Altekruse | |
| P2860 | cites work | Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 |
| Molecular portraits of human breast tumours | Q28032461 | ||
| Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype | Q28271274 | ||
| Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer | Q29616112 | ||
| US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status | Q30665329 | ||
| Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control | Q30822410 | ||
| Socioeconomic disparities in breast cancer survival: relation to stage at diagnosis, treatment and race | Q33510425 | ||
| Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. | Q33669007 | ||
| Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers. | Q33757796 | ||
| Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer | Q34601123 | ||
| Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups | Q34613569 | ||
| Trends in breast cancer stage and mortality in Michigan (1992-2009) by race, socioeconomic status, and area healthcare resources | Q34700700 | ||
| Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status | Q34705321 | ||
| Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies | Q34982473 | ||
| Age at cancer diagnosis for blacks compared with whites in the United States | Q35078561 | ||
| Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors | Q35801283 | ||
| Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study | Q35815602 | ||
| Triple-negative breast cancer and obesity in a rural Appalachian population | Q36333924 | ||
| Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment | Q36514371 | ||
| Individual and neighborhood socioeconomic status and healthcare resources in relation to black-white breast cancer survival disparities | Q36663508 | ||
| Triple negative tumours: a critical review | Q37048793 | ||
| Triple-negative/basal-like breast cancer: review | Q37352934 | ||
| Pharmacotherapy of triple-negative breast cancer | Q37565645 | ||
| Triple-negative breast cancer: epidemiological considerations and recommendations | Q38046586 | ||
| Breast cancer statistics, 2013. | Q38151550 | ||
| Breast cancer disparities: high-risk breast cancer and African ancestry | Q38216566 | ||
| Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study | Q39605778 | ||
| Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer | Q39689209 | ||
| Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. | Q39837918 | ||
| The association of metabolic syndrome with triple-negative breast cancer | Q39936272 | ||
| Black residential segregation, disparities in spatial access to health care facilities, and late-stage breast cancer diagnosis in metropolitan Detroit | Q39941867 | ||
| Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma | Q42466578 | ||
| Breast cancer molecular subtypes respond differently to preoperative chemotherapy | Q42482998 | ||
| Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance | Q42503057 | ||
| Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry | Q42510173 | ||
| The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes | Q42511189 | ||
| Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival | Q42520439 | ||
| Basal cell-like (triple-negative) breast cancer, a predictor of distant metastasis in African American women | Q42522562 | ||
| The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004. | Q42642063 | ||
| Race, socioeconomic status, and breast cancer treatment and survival | Q44271644 | ||
| Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapy | Q44423612 | ||
| Differences in breast cancer stage, treatment, and survival by race and ethnicity | Q45287347 | ||
| Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. | Q46305340 | ||
| Trends in breast cancer by race and ethnicity: update 2006. | Q46557916 | ||
| Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation | Q46606944 | ||
| p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes | Q46714384 | ||
| Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer | Q46771645 | ||
| 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. | Q53243856 | ||
| Racial/ethnic and socioeconomic differences in short-term breast cancer survival among women in an integrated health system. | Q53805731 | ||
| HER2 and Response to Paclitaxel in Node-Positive Breast Cancer | Q57578418 | ||
| Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer | Q57895974 | ||
| Is race a poor prognostic factor in breast cancer? | Q77988611 | ||
| Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma | Q79899271 | ||
| Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer Project | Q81903778 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 211-218 | |
| P577 | publication date | 2015-08-07 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Breast cancer survival in African-American women by hormone receptor subtypes | |
| P478 | volume | 153 |
| Q38613569 | Availability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality among Blacks and Whites |
| Q92803879 | Breast Cancer Incidence and Mortality by Molecular Subtype: Statewide Age and Racial/Ethnic Disparities in New Jersey |
| Q88801211 | Breast cancer metastasis through the lympho-vascular system |
| Q40228854 | Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in US women 18 to 64 years old. |
| Q35989438 | Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer |
| Q64982232 | Overall Survival and Local Recurrence Among Breast Cancer Patients in Hospital Sultanah Nora Ismail Batu Pahat, 2007-2013 |
| Q37018305 | Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources. |
| Q40975730 | Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee |
| Q33592950 | The Landscape of Randomised Controlled Trials of Therapies in Breast Cancer in Low and Middle Income Countries. |
| Q87955279 | Time to Clinical Follow-up after Abnormal Mammogram among African American and Hispanic Women |
Search more.